Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 11/2010

01-11-2010 | Breast Oncology

Tissue Expander Breast Reconstruction is Not Associated with an Increased Risk of Lymphedema

Authors: Tomer Avraham, MD, Sanjay V. Daluvoy, MD, Elyn R. Riedel, MA, Peter G. Cordeiro, MD, Kimberly J. Van Zee, MS, MD, Babak J. Mehrara, MD

Published in: Annals of Surgical Oncology | Issue 11/2010

Login to get access

Abstract

Background

Recent reports have demonstrated that lymphedema can occur after even minor pertubation of the axillary region such as sentinel lymph node biopsy (SLNB). The impact of breast reconstruction on the development of lymphedema, however, remains unknown. Therefore, the purpose of this study was to determine the impact of immediate tissue expander breast reconstruction on the risk of developing lymphedema.

Materials and Methods

We identified patients who had undergone mastectomy with SLNB or SLNB and axillary lymph node dissection (ALND) with or without breast reconstruction using our prospectively maintained lymphedema and breast reconstruction databases. The development of lymphedema was evaluated prospectively using arm measurements and a validated questionnaire. Associations between variables were examined. Logistic regression was used to examine the association of reconstruction on prevalence of lymphedema while adjusting individually for BMI, age, and weight gain after surgery.

Results

Characteristics of patients with or without reconstruction were similar except for age, BMI, and weight gain since surgery. Median follow-up was 5 years. Among patients treated with mastectomy with SLNB or SLNB/ALND, those undergoing reconstruction had a lower rate of measured lymphedema than those who did not (5% vs. 18%, P < .0004). The reconstructed group also had fewer patients with both measured and self-reported lymphedema (3% vs. 12%, P < .002). Differences in the rates of measured lymphedema between groups persisted following univariate logistical regression for differences in age, BMI, and weight gain.

Conclusions

Tissue expander breast reconstruction in patients undergoing SLNB or SLNB/ALND does not increase the risk of developing measured or perceived lymphedema.
Literature
1.
Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.CrossRefPubMed
2.
Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3:208–17.CrossRefPubMed
3.
McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26:5220–6.CrossRefPubMed
4.
McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213–9.CrossRefPubMed
5.
Elder EE, Brandberg Y, Björklund T, Rylander R, Lagergren J, Jurell G, et al. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. Breast. 2005;14:201–8.CrossRefPubMed
6.
Preminger BA, Pusic AL, McCarthy CM, Verma N, Worku A, Cordeiro PG. How should quality-of-life data be incorporated into a cost analysis of breast reconstruction? A consideration of implant versus free TRAM flap procedures. Plast Reconstr Surg. 2008;121:1075–82.CrossRefPubMed
7.
Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92:1422–9.CrossRefPubMed
8.
Vandeweyer E, Hertens D, Nogaret JM, Deraemaecker R. Immediate breast reconstruction with saline-filled implants: no interference with the oncologic outcome? Plast Reconstr Surg. 2001;107:1409–12.CrossRefPubMed
9.
McCarthy CM, Pusic AL, Sclafani L, Buchanan C, Fey JV, Disa JJ, et al. Breast cancer recurrence following prosthetic, postmastectomy reconstruction: incidence, detection, and treatment. Plast Reconstr Surg. 2008;121:381–8.CrossRefPubMed
10.
Langstein HN, Cheng MH, Singletary SE, Robb GL, Hoy E, Smith TL, et al. Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg. 2003;111:712–20 (discussion 721–2).CrossRefPubMed
11.
Huang CJ, Hou MF, Lin SD, Chuang HY, Huang MY, Fu OY, et al. Comparison of local recurrence and distant metastases between breast cancer patients after postmastectomy radiotherapy with and without immediate TRAM flap reconstruction. Plast Reconstr Surg. 2006;118:1079–86 (discussion 1087–8).CrossRefPubMed
12.
Vandeweyer E, Deraemaecker R, Nogaret JM, Hertens D. Immediate breast reconstruction with implants and adjuvant chemotherapy: a good option? Acta Chir Belg. 2003;103:98–101.PubMed
13.
Howard MA, Polo K, Pusic AL, Cordeiro PG, Hidalgo DA, Mehrara B, et al. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg. 2006;117:1381–6.CrossRefPubMed
14.
Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–9.CrossRefPubMed
15.
Cody HS III. The learning curve for sentinel lymph node biopsy in breast cancer. Arch Surg. 2000;135:605–6.CrossRefPubMed
16.
17.
Mak SS, Yeo W, Lee YM, Mo KF, Tse KY, Tse SM, et al., Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong. Nurs Res. 2008;57:416–25.CrossRefPubMed
18.
Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405–11.CrossRefPubMed
19.
Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37:73–91.PubMed
20.
Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006;15:153–65.CrossRefPubMed
21.
Soran A, D’Angelo G, Begovic M, Ardic F, Harlak A, Samuel Wieand H, et al. Breast cancer-related lymphedema—what are the significant predictors and how they affect the severity of lymphedema? Breast J. 2006;12:536–43.CrossRefPubMed
22.
Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs. Cancer. 2007;109:2607–14.CrossRefPubMed
23.
Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–52.CrossRefPubMed
24.
Hinrichs CS, Watroba NL, Rezaishiraz H, Giese W, Hurd T, Fassl KA, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol. 2004;11:573–80.CrossRefPubMed
Metadata
Title
Tissue Expander Breast Reconstruction is Not Associated with an Increased Risk of Lymphedema
Authors
Tomer Avraham, MD
Sanjay V. Daluvoy, MD
Elyn R. Riedel, MA
Peter G. Cordeiro, MD
Kimberly J. Van Zee, MS, MD
Babak J. Mehrara, MD
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 11/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1112-2

Other articles of this Issue 11/2010

Annals of Surgical Oncology 11/2010 Go to the issue

Endocrine Tumors

25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients with Primary Hyperparathyroidism

Colorectal Cancer

Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer

Head and Neck Oncology

Association of High Levels of Jagged-1 and Notch-1 Expression with Poor Prognosis in Head and Neck Cancer

Translational Research and Biomarkers

Clinical Significance of Human Kallikrein7 Gene Expression in Colorectal Cancer

Breast Oncology

Minimal Disease in the Sentinel Lymph Node: How to Best Measure Sentinel Node Micrometastases to Predict Risk of Additional Non-Sentinel Lymph Node Disease

Bone and Soft Tissue Sarcomas

Osteosarcoma of the Proximal Tibia: Limb-Sparing Resection and Reconstruction with a Modular Segmental Proximal Tibia Tumor Prosthesis